MetaCap

LENZ Therapeutics (LENZ) News

NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.97-0.375 (-11.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LENZ news summary

We found 3 recent headlines mentioning LENZ Therapeutics (LENZ): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. LENZ is making an outsized move today, down 11.23% at $2.97, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "LENZ (LENZ) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 2, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest LENZ Therapeutics headlines

Stocks mentioned alongside LENZ

Compare LENZ